Innovation Events

Hosted by Dr Joanne Pike, Chair of the World Dementia Council and President & CEO of the Alzheimer’s Association. This working lunch will bring together global leaders, researchers, and industry experts to explore innovation in clinical trials and the development of treatments for Alzheimer’s disease and other dementia. The lunch takes place during CTAD 2026 held in San Diego. 

Chaired by Dr Niranjan Bose (Managing Director, Health & Life Sciences, Gates Ventures) and Dr Stacie Weninger (President, FBRI), this virtual dialogue will explore how AI is transforming dementia research, diagnostics and care. Bringing together global leaders from science, technology, and policy, participants will discuss how artificial intelligence can accelerate discovery, enable precision approaches, and support real-world implementation across diverse health systems.

Chaired by Dr Howard Fillit, Chief Science Officer Alzheimer's Drug Discovery Fund and Dr Stacie Weninger President of FBRI, this virtual dialogue explored the different experiences, and the lessons from that, of companies and funders innovating in the biomarker field. It began with opening remarks from Randall Bateman, Charlotte Teunissen, Michael Weiner and Henrik Zetterberg followed by a roundtable discussion.